NovoCure Ltd — Director's Dealing 2016

Jan 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-01-04

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	Ordinary Shares	M	332984	$0.17	Acquired	334084	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	Options to Buy Ordinary Shares	$0.17	M	332984	Disposed	2016-07-01	Ordinary Shares (332984)	Direct

Footnotes

F1: Fully vested and currently exercisable as of the date hereof.